Statement 22 May 2019

IFPMA Statement at WHA72 agenda item 1.5 Universal Health Coverage


IFPMA stands together with the global health community to support Member States in accelerating efforts to achieve UHC. We also welcome the recognition that UHC must include access to affordable and quality-assured medicines, vaccines and health products.

Through our work in novel partnerships with governments, NGOs, and private sector entities, the industry is supporting UHC through health systems strengthening – ensuring the quality and integrity of the supply chain, training health care workers, and exploring innovative approaches to financing health coverage.

IFPMA believes that structured, collaborative action on UHC is needed to meet the shared goals of expanding patient access to medicines through innovative solutions, and achieving long-term sustainability of the health sector. This is all the more necessary given the complex mix of interconnected threats to global health which we increasingly face —from poverty and pandemics to conflict and environmental issues.

In the run-up to the UN High Level Meeting in September and as a Core Member of the Private Sector Constituency of UHC 2030, we are pleased to see the Key Asks from the UHC movement going in the right direction. We support in particular the need to uphold quality primary health care, drive forward sustainable financing, and provide an enabling environment to promote improved access to medicines and vaccines, facilitating continued innovation to find new treatments and cures that ensure no-one is left behind.

Now is the time to take action and step forward together in expanding quality health coverage – and to see it not as a cost but as a genuine investment in our human capital, as the drivers of economic development and growth. We look forward to continuing a constructive and inclusive debate on how to help countries move forward on achieving UHC.


The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit

Learn more

Media Contact

Elliot Dunster